SIGA Technologies, Inc. (NASDAQ:SIGA)
A bio-defense company engaged in the discovery, development and commercialization of products for use in defense against biological warfare agents such as Smallpox and Arenaviruses.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
This is more of a technical call for me. Following the relatively large insider accumulation taking place, and counting on the large short interest to act as rocket fuel for the very nice chart that is beginning to form.
I did read a little today about the Broad-Spectrum Antiviral, ST-669, and it sounds fantastic. This drug could turn into a large seller with multiple uses, although that is probably years down the road. I am not betting on an approval anytime soon, but a partnering with a larger drug maker or additional financing for this potential drug could be just the catalyst this stock needs to go much higher. Just my two cents.
Recs
playing the lottery
Recs
They are the only company with a drug that actually meets the RFP. Siga's drug works...there are no other options.
I thought negotiating a deal wasn't "doing a deal". Nothing was signed? How can they be forced to share 50% of the upside for a 3M loan which they paid back in full with interest.
Recs
Tracking the insider buying of the directors and chief scientific officers, their sum total investments from 5/19/11 tally to 6.26 million dollars. They bought at a average of 13.33$ a share. Simply what this means is their product is heavily undervalued if their most informed are buying thousands of shares at $13+ a share. Another key component is the short sellers putting heavy downward stress on the stock. Yesterday SIGA hit its 52 week low. With a meeting with Goldman Sachs on Aug 2 discussing small cap healthcare and with earnings approaching august 1st, investors will see decent news as positive news. Lastly with the signing of the BARDA contract, the government should begin buying shortly ST-246 anti viral vaccinations for small pox. With the Debt ceiling proposal looming over the US, positive news potentially will yield FDI (foreign direct investment) especially since democrats want to shield medicare and medicaid and any other healthcare programs. Id give this stock 70% chance to pop as of august 1st earnings.
Recs
Following ZZ on this one
Recs
Extremely High Price for Book Value
Recs
With the contract award, this stock is poised to take off. Figuring the amount of the award, w/ extensions, this stock should double.
Recs
http://marketplayground.com/2011/03/28/siga-technologies-nasdaqsiga-how-long-do-we-wait-on-barda/
Recs
I reckon the odds are +- 50% that the stock will rocket 2-300% and 50% it will fall 50%; those are my kind of odds!
Recs
Gonna have to go with my man Bays here
Recs
The contract with BARDA will come through and the stock will run.
Recs
They have the only drug that works against small pox.
Recs
Hard to see how SIGA isn't worth multiples of its current price given its recent contract award. Outperform.
Our recent write-up is linkied below...
http://www.aboveaverageodds.com/2010/11/23/investment-analysis-siga-technologies-siga-2/
Recs
39,39,16
55,91,59
Recs
The competition is 3 years behind should the goverment wait for them? Israel preparing for something big war continuing and terrorists ramping up their efforts. Prospects for siga are still good and the excitement in december Scared alot of investors and made good for the ones who were in for a quick hit. I am staying on this rocket and don't want to be in the stands when it takes off. Patience!
Recs
SIGA will reclaim territry it recently sold off of.
Recs
Too much positive to list for SIGA but they are gearing up for commercialization of the product have presented to BARDA and the World Health Organization. SIGA has also finalized the market image and packaging of the commercial material.
Recs
Their technology is excellent and they have a strong patent position around their potential therapeutics.
Recs
They are bleeding money and quite frankly, I'd be surprised if they didn't go bankrupt in the coming months.
Recs
They have no competition for Federal RFP for millions of courses with results to be announced in Sept. 09. Added to that are the worldwide concerns of a smallpox pandemic resulting from the increased threats of bio terrorism.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 46 : 1 2 3 Next »